Author:
Jung Kyung Oh,Theruvath Ashok Joseph,Nejadnik Hossein,Liu Anna,Xing Lei,Sulchek Todd,Daldrup-Link Heike E.,Pratx Guillem
Abstract
AbstractRegenerative medicine uses the patient own stem cells to regenerate damaged tissues. Molecular imaging techniques are commonly used to image the transplanted cells, either right after surgery or at a later time. However, few techniques are fast or straightforward enough to label cells intraoperatively. Adipose tissue-derived stem cells (ADSCs) were harvested from knee joints of minipigs. The cells were labeled with PET contrast agent by flowing mechanoporation using a microfluidic device. While flowing through a series of microchannels, cells are compressed repeatedly by micro-ridges, which open transient pores in their membranes and induce convective transport, intended to facilitate the transport of 68Ga-labeled and lipid-coated mesoporous nanoparticles (MSNs) into the cells. This process enables cells to be labeled in a matter of seconds. Cells labeled with this approach were then implanted into cartilage defects, and the implant was imaged using positron emission tomography (PET) post-surgery. The microfluidic device can efficiently label millions of cells with 68Ga-labeled MSNs in as little as 15 min. The method achieved labeling efficiency greater than 5 Bq/cell on average, comparable to 30 min-long passive co-incubation with 68Ga-MSNs, but with improved biocompatibility due to the reduced exposure to ionizing radiation. Labeling time could also be accelerated by increasing throughput through more parallel channels. Finally, as a proof of concept, ADSCs were labeled with 68Ga-MSNs and quantitatively assessed using clinical PET/MR in a mock transplant operation in pig knee joints. MSN-assisted mechanoporation is a rapid, effective and straightforward approach to label cells with 68Ga. Given its high efficiency, this labeling method can be used to track small cells populations without significant effects on viability. The system is applicable to a variety of cell tracking studies for cancer therapy, regenerative therapy, and immunotherapy.
Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Squillaro, T., Peluso, G. & Galderisi, U. Clinical trials with mesenchymal stem cells: An update. Cell Transpl. 25, 829–848 (2016).
2. Coughlin, R. P., Oldweiler, A., Mickelson, D. T. & Moorman, C. T. 3rd. Adipose-derived stem cell transplant technique for degenerative joint disease. Arthrosc. Tech. 6, e1761–e1766 (2017).
3. Henning, T. D. et al. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells in cartilage defects: In vitro and in vivo investigations. Mol. Imaging 11, 197–209 (2011).
4. Theruvath, A. J. et al. Tracking stem cell implants in cartilage defects of minipigs by using ferumoxytol-enhanced MRI. Radiology 292, 129–137 (2019).
5. Kircher, M. F., Gambhir, S. S. & Grimm, J. Noninvasive cell-tracking methods. Nat. Rev. Clin. Oncol. 8, 677–688 (2011).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献